83 related articles for article (PubMed ID: 12958847)
1. [Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates].
Zhou SY; Mei QB; Liu L; Zhang BL; Li C; Zhou J
Yao Xue Xue Bao; 2003 May; 38(5):388-91. PubMed ID: 12958847
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
McLeod AD; Friend DR; Tozer TN
J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
5. Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis.
Zhou SY; Mei QB; Liu L; Guo X; Qiu BS; Zhao DH; Cho CH
Acta Pharmacol Sin; 2001 Aug; 22(8):761-4. PubMed ID: 11749853
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat.
McLeod AD; Tolentino L; Tozer TN
Biopharm Drug Dispos; 1994 Mar; 15(2):151-61. PubMed ID: 7516722
[TBL] [Abstract][Full Text] [Related]
8. Dextran carrier macromolecule for colon specific delivery of celecoxib.
Shrivastava PK; Shrivastava SK
Curr Drug Deliv; 2010 Apr; 7(2):144-51. PubMed ID: 20158488
[TBL] [Abstract][Full Text] [Related]
9. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.
Pang YN; Zhang Y; Zhang ZR
World J Gastroenterol; 2002 Oct; 8(5):913-7. PubMed ID: 12378641
[TBL] [Abstract][Full Text] [Related]
11. [Study on the enzyme dependant colon targeting prodrug--dexamethasone succinate dextran and its tablets].
Pang YN; Zhang ZR; Pang QJ; Li TL
Yao Xue Xue Bao; 2001 Aug; 36(8):625-30. PubMed ID: 12579944
[TBL] [Abstract][Full Text] [Related]
12. A new natural angelica polysaccharide based colon-specific drug delivery system.
Zhou S; Zhang B; Liu X; Teng Z; Huan M; Yang T; Yang Z; Jia M; Mei Q
J Pharm Sci; 2009 Dec; 98(12):4756-68. PubMed ID: 19408300
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.
Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM
J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.
Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y
Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576
[TBL] [Abstract][Full Text] [Related]
15. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
Haeberlin B; Rubas W; Nolen HW; Friend DR
Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid.
Lee JS; Jung YJ; Doh MJ; Kim YM
Drug Dev Ind Pharm; 2001 Apr; 27(4):331-6. PubMed ID: 11411900
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
Hirayama F; Minami K; Uekama K
J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac-dextran conjugates: synthesis, in vitro and in vivo evaluation.
Vyas S; Trivedi P; Chaturvedi SC
Acta Pharm; 2007 Dec; 57(4):441-50. PubMed ID: 18165188
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation.
Yavuz B; Bozdağ Pehlivan S; Sümer Bolu B; Nomak Sanyal R; Vural İ; Ünlü N
J Pharm Pharmacol; 2016 Aug; 68(8):1010-20. PubMed ID: 27283886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
